跳至主要内容
临床试验/NCT06935877
NCT06935877尚未招募4 期

Comparison of the Efficacy of Combined Hyaluronic Acid and Triamcinolone Acetonide Injection and Hyaluronic Acid Alone Injection in Patients With Subdeltoid Bursitis

Shin Kong Wu Ho-Su Memorial Hospital0 个研究点目标入组 60 人开始时间: 2025年4月25日最近更新:
干预措施

试验速览

阶段
4 期
状态
尚未招募
入组人数
60
主要终点
Shoulder Pain and Disability Index

研究概览

简要总结

The study employs a double-blind, randomized clinical trial design with 60 patients diagnosed with subdeltoid bursitis. Participants are divided into two groups: the experimental group receives combined hyaluronic acid and Triamcinolone Acetonide injections, while the control group receives hyaluronic acid alone injection. All injections are guided by ultrasound. Assessments are conducted before treatment and at 1 week, 1 month, and 3 months post-treatment.

详细描述

Evaluation indicators include pain (measured by Visual Analog Scale for rest, activity, and sleep, and pain threshold via pressure algometer), function (assessed by Disabilities of the Arm, Shoulder, and Hand score and Shoulder Pain and Disability Index), quality of life (using the World Health Organization Quality of Life-BREF).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - Unilateral shoulder pain within the past 3 months
  • Pain during joint movements such as abduction or internal rotation
  • At least one positive result from the following tests: Painful arc, Neer test, or Hawkins test
  • No shoulder injections received in the past 3 months
  • Willingness to receive injection treatment and undergo follow-up assessments at the following time points:
  • Immediate (1 week after injection)
  • Short-term (1 month after injection)
  • Mid-term (3 months after injection)
  • Avoid use of anti-inflammatory painkillers during the study period as much as possible; if intolerable pain occurs, acetaminophen (provided by the researcher) will be used to relieve symptoms

排除标准

  • Presence of infectious disease, inflammation, rheumatoid arthritis, or fracture
  • History of malignancy
  • Previous shoulder surgery
  • Sensory deficits
  • Tendon rupture of the rotator cuff or biceps tendon
  • Neurological disorders causing hand weakness or affecting shoulder mobility (e.g., stroke, Parkinson's disease, brachial plexus injury, peripheral neuropathy)
  • Cognitive impairment preventing completion of questionnaires
  • Cervical radiculopathy
  • Diagnosed frozen shoulder (adhesive capsulitis)
  • Psychiatric disorders
  • Breastfeeding or pregnant women
  • Received shoulder injection within the past 3 months, including corticosteroids, hyaluronic acid, Platelet-rich plasma, or any prolotherapy solution

研究组 & 干预措施

Intervention group

Experimental

traditional rehabilitation programs

干预措施: Hyaluronic acid injection (Drug)

Intervention group

Experimental

traditional rehabilitation programs

干预措施: Triamcinolone Acetonide injection (Drug)

Control

Active Comparator

Hyaluronic acid injection

干预措施: Hyaluronic acid injection (Drug)

结局指标

主要结局

Shoulder Pain and Disability Index

时间窗: Score change from baseline to 1 week, 1 months and 3 months of treatment, higher score, the better outcome

A questionnaire to evaluate the severity of shoulder pain and disability in patients with shoulder problems; higher scores indicated more significant pain and disability.The score ranges from 0 to 100: 0 = no disability; 100 = most severe disability

次要结局

  • Score change from baseline to 1 week, 1 months and 3 months of treatment, higher score, the better outcome(Score change from baseline to 1 week, 1 months and 3 months of treatment, higher score, the better outcome)
  • Disabilities of the Arm, Shoulder, and Hand(Score change from baseline to 1 week, 1 months and 3 months of treatment, higher score, the better outcome)
  • World Health Organization Quality of Life(Score change from baseline to 1 week, 1 months and 3 months of treatment, higher score, the better outcome)
  • visual analog scale(Score change from baseline to 1 week, 1 months and 3 months of treatment, higher score, the better outcome)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ru-Lan Hsieh

MD

Shin Kong Wu Ho-Su Memorial Hospital

相似试验